Connor, Clark & Lunn Investment Management (CC&L)’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$1.56M Buy
2023
Q4
$1.79M Buy
2023
Q3
$219K Buy
2023
Q2
$41K Buy